- Home
- DNTH vs CNMD Comparison
DNTH vs CNMD Comparison
Compare DNTH & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- CNMD
- Stock Information
- Founded
- DNTH 2015
- CNMD 1970
- Country
- DNTH United States
- CNMD United States
- Employees
- DNTH N/A
- CNMD N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DNTH Health Care
- CNMD Health Care
- Exchange
- DNTH Nasdaq
- CNMD Nasdaq
- Market Cap
- DNTH 1.5B
- CNMD 1.7B
- IPO Year
- DNTH N/A
- CNMD 1987
- Fundamental
- Price
- DNTH $36.05
- CNMD $45.01
- Analyst Decision
- DNTH Strong Buy
- CNMD Hold
- Analyst Count
- DNTH 11
- CNMD 5
- Target Price
- DNTH $65.22
- CNMD $59.80
- AVG Volume (30 Days)
- DNTH 664.6K
- CNMD 375.8K
- Earning Date
- DNTH 11-06-2025
- CNMD 11-05-2025
- Dividend Yield
- DNTH N/A
- CNMD 1.78%
- EPS Growth
- DNTH N/A
- CNMD 12.82
- EPS
- DNTH N/A
- CNMD 3.54
- Revenue
- DNTH $4,854,000.00
- CNMD $1,326,244,000.00
- Revenue This Year
- DNTH N/A
- CNMD $6.73
- Revenue Next Year
- DNTH N/A
- CNMD $5.45
- P/E Ratio
- DNTH N/A
- CNMD $12.70
- Revenue Growth
- DNTH 17.87
- CNMD 3.94
- 52 Week Low
- DNTH $13.37
- CNMD $42.50
- 52 Week High
- DNTH $40.16
- CNMD $78.00
- Technical
- Relative Strength Index (RSI)
- DNTH 57.06
- CNMD 39.98
- Support Level
- DNTH $33.34
- CNMD $42.51
- Resistance Level
- DNTH $36.68
- CNMD $45.57
- Average True Range (ATR)
- DNTH 2.11
- CNMD 1.68
- MACD
- DNTH -0.53
- CNMD -0.02
- Stochastic Oscillator
- DNTH 39.74
- CNMD 42.11
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.